Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic
Open Access
- 8 June 2005
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 30 (11) , 1963-1985
- https://doi.org/10.1038/sj.npp.1300772
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosineNeuropharmacology, 2003
- Reversal of Phencyclidine-Induced Dopaminergic Dysregulation by N-Methyl-D-Aspartate Receptor/Glycine-site AgonistsNeuropsychopharmacology, 2003
- Hippocampal neurons in schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- N[3‐(4′‐fluorophenyl)‐3‐(4′‐phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transportBritish Journal of Pharmacology, 2001
- Glycine transport inhibitors as potential antipsychotic drugsEmerging Therapeutic Targets, 2001
- Episodic memory and learning in patients with chronic schizophreniaSchizophrenia Research, 1998
- Functional and Anatomical Aspects of Prefrontal Pathology in SchizophreniaSchizophrenia Bulletin, 1997
- Clinical Experience With Excitatory Amino Acid Antagonist DrugsStroke, 1995
- Chronic mild stress-induced anhedonia: A realistic animal model of depressionNeuroscience & Biobehavioral Reviews, 1992
- Distress vocalization in rat pups a simple screening method for anxiolytic drugsJournal of Pharmacological Methods, 1985